Found 6 matching trials
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients PHASE4 The objective of the study is to compare the cardiovascular profile of an e...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation PHASE3 Background:
Hepatitis C recurrence, which invariably occurs in viremic liv...
Show More Location
Department of HPB Surgery and Transplant, Hospital Vall d´Hebron
Learn More & Join Trial
Renal Transplantation in the Elderly - nEverOld Study PHASE4 An exploratory study of the efficacy and safety of a regimen consisted of E...
Show More Location
Clinical Hospital of the School of Medicine, University of Sao Paulo
Learn More & Join Trial
Regimen Optimization Study PHASE2 Patients who undergo a kidney transplant require prolonged therapy with dru...
Show More Location
California Institute Of Renal Research
Learn More & Join Trial
Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population PHASE4 This is an open, randomized, single-center study. The selected patients wil...
Show More Location
Instituto de Urologia e Nefrologia
Learn More & Join Trial
Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response PHASE4 Kidney transplant patients under an immunosuppressive treatment based on an...
Show More Location
Hospital Universitari de Bellvitge
Learn More & Join Trial